Biomarkers, Diagnostics and Precision Medicine in the Drug Industry: Critical Challenges, Limitations and Road Maps for the Best Practices
- 出版商: Academic Press
- 出版日期: 2019-06-11
- 售價: $4,340
- 貴賓價: 9.5 折 $4,123
- 語言: 英文
- 頁數: 294
- 裝訂: Quality Paper - also called trade paper
- ISBN: 0128161213
- ISBN-13: 9780128161210
Biomarkers, Diagnostics, and Precision Medicine in the Drug Industry: Critical Challenges, Limitations and Road Maps for the Best Practices examines the challenges and limitations in biomarkers and laboratory tests, offering advice on best practices to ensure the proper application of biomarkers and bridging the gap between diagnostic business development claims and real-life deliverables. The book covers biomarkers for different purposes, provides examples from different technologies, including standard-of-care approved assays and for-investigational-use and for-research-use-only assays. The book also includes new data for biomarkers in different therapeutic indications and offers case studies and practical examples.
Users will find this to be an ideal resource that is perfect for drug developers, IVD providers, healthcare givers, academics and researchers who need best practices to help them increase their probability of success.
- Provides the unique insights of an expert with extensive experience in diagnostics, clinical laboratories, and drug discovery and development
- Addresses the challenges of drug development and precision medicine and suggests how to eliminate or mitigate these challenges through better utilization of biomarkers
- Features case studies and real-life examples from different classes of biomarkers on different platforms for different therapeutic areas